Annual Drug Patent Expirations for SLYND
Slynd is a drug marketed by Exeltis Usa Inc and is included in one NDA. It is available from one supplier. There are thirteen patents protecting this drug.
Drug patent litigation for SLYND.
This drug has fifty-five patent family members in twenty-nine countries.
The generic ingredient in SLYND is drospirenone. One supplier is listed for this compound. Additional details are available on the drospirenone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
